GO
Loading...

Insurance

More

  • Investors Are Eating Pfizer's Lunch Tuesday, 27 Jan 2009 | 2:44 PM ET

    Reporters could only listen to Pfizer's hastily-organized "Investor Luncheon," so I can't tell you how many people showed up or what the room looked like. But Chairman and CEO Jeff Kindler drew a pretty good picture at the start of his opening remarks.

  • Pfizer's Kindler Continues To Make His Case Tuesday, 27 Jan 2009 | 12:18 PM ET

    This is the first paragraph/short story.

  • The Politics And Science Of Geron Friday, 23 Jan 2009 | 2:57 PM ET
    Geron

    A few days into his term, President Obama appears to have begun to undo another Bush-era policy. He hasn't yet formally lifted the Bush-imposed ban on federal funding of new embryonic stem cell research, but Obama's Food and Drug Administration has already set the stage for it.

  • Pfizer Smells A Rat In Drug Counterfeiting Thursday, 22 Jan 2009 | 12:07 PM ET

    For years pharmaceutical companies and health authorities have been trying to crack down on counterfeit prescription drugs. But on a new United Kingdom website the world's biggest drug company, Pfizer, is apparently taking the fight against knockoffs to a whole nutha level.

  • Nissen: Plainspeaking In The Plain-Dealer Wednesday, 21 Jan 2009 | 12:31 PM ET
    Dr. Steven Nissen

    Dr. Steven Nissen, the cardiology chief at the Cleveland Clinic, reportedly remains on the shortlist to possibly become the next FDA Commissioner. Some analysts believe if Dr. Nissen gets the nod there could be a negative knee-jerk reaction in the big pharma sector stocks.

  • As Bank Crisis Deepens, Obama Has No Quick Fix Wednesday, 21 Jan 2009 | 5:12 AM ET

    Even before they have settled into their new jobs, President Obama’s economic team faces an acute crisis in the nation’s banking system that has no easy answers and that they are not yet prepared to address, the New York Times reported.

  • J&J Drugs & Drug-Coated Stents Take A Big Hit Tuesday, 20 Jan 2009 | 12:44 PM ET

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • UPDATE: How to Fight Your Health Insurer ... and Win Friday, 16 Jan 2009 | 12:55 PM ET

    The UnitedHealth settlement over out-of-network medical costs has huge implications for all of us. For one, it shows that the consumer can still effect change.

  • The Most Expensive Consumer Cost of All Friday, 16 Jan 2009 | 11:16 AM ET

    Consumer prices may be falling, but what does it matter when health care costs are skyrocketing?

  • Steve Jobs: Can His Case Help Propel Biopharma? Thursday, 15 Jan 2009 | 2:17 PM ET

    Even though it's one of the leading causes of cancer death in the U.S., pancreatic normally doesn't get much attention.

  • A recession means making tough money decisions. But for some, it quite literally means the difference between life and death.

  • Cramer: Why You Can't Own Banks, Insurers Wednesday, 14 Jan 2009 | 7:30 PM ET

    And that's not all. Energy plays, housing stocks, retailers – they're all victims of an under-the-radar trend in the markets.

  • The Biggest Insurance Scheme of All Time? Wednesday, 14 Jan 2009 | 12:37 PM ET

    Even if you're insured, you are not immune from sky-high medical bills. One cancer patient found out the hard way - and did something about it.

  • Genentech's Quiet Period Times Two Wednesday, 14 Jan 2009 | 10:45 AM ET

    I couldn't go to the formal, scripted Genentech presentation at the JPMorgan Healthcare Conference yesterday afternoon because I was busy doing the crazy interview on "Fast Money" with the CEO of athenahealth, Jonathan Bush. I've never done a CEO interview like it.

  • Web Extra: Avoid These Healthcare Traps Tuesday, 13 Jan 2009 | 10:35 PM ET

    Insurance companies take care of their bottom line before they worry about taking care of you. Here's what to know to make sure you aren't being taken for a ride.

  • More and more seemingly law-abiding citizens are torching their cars, reporting them stolen and filing insurance claims. And it's affecting all of us.

  • A Tale Of Two Industries Tuesday, 13 Jan 2009 | 12:25 PM ET
    Jamie Dimon

    During his lunchtime keynote speech here at the JPMorgan Healthcare Conference JPM Chairman and CEO Jamie Dimon was asked to give his worst-case scenario for the economy. He said that'd be a 1982-type recession lasting about two years and with unemployment "North of 10 percent." Dimon said it would be "Irrational to not be prepared for that."

  • What Ever Happened to Moral Hazard? Monday, 12 Jan 2009 | 9:27 PM ET

    We haven’t heard that phrase since Lehman Brothers imploded. Wonder why.

  • Is Roche In A Rush For Genentech? Monday, 12 Jan 2009 | 1:35 PM ET
    Roche CFO's presentation at the JPMorgan Healthcare Conference

    Not surprisingly it was standing room only in the grand ballroom of the Westin St. Francis Hotel in San Francisco for the Roche presentation this morning at the JPMorgan Healthcare Conference.

  • JPMorgan Conference Feels Wall Street Pinch Monday, 12 Jan 2009 | 11:44 AM ET

    I'm covering the 27th Annual JPMorgan Healthcare Conference in San Francisco where I suspect there will be a big crowd for the Roche presentation later this morning. It's being reported that the Swiss drugmaker may soon raise its bid for Genentech. I'll be shocked if Roche says much about it either in the formal presentation or breakout session. But I'll be there just in case.

Contact Insurance

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Most Popular Video

Thursday, 17 Apr 2014 | 4:13 PM ET

Dissecting today's market activity and the current state of financials, with Yra Harris, Praxis Trading partner; Larry Glazer, Mayflower Advisors; CNBC contributor Carol Roth; "Fast Money" Guy Adami and CNBC's Kate Kelly.

Thursday, 17 Apr 2014 | 5:46 PM ET

CNBC voice over talent Jim Birdsall shares the top 5 sayings from traders on "Fast Money" over the years.

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.